| Literature DB >> 32494346 |
Mojtaba Mohammadzadeh-Vazifeh1, Seyed Masoud Hosseini1, Ali Mohammadi2, Mahdi Jahanfar3, Hadi Maleki1.
Abstract
BACKGROUND AND OBJECTIVES: In recent years, active packaging has been introduced as a new method to better preserve food. Chitosan and nanoclay have been used for preparation of an active nanocomposite with respect to their antimicrobial properties to investigate its effects on the microbial limitation in Gouda cheese.Entities:
Keywords: Antimicrobial property; Chitosan; Gouda cheese; Nanoclay; Nanocomposite
Year: 2020 PMID: 32494346 PMCID: PMC7244818
Source DB: PubMed Journal: Iran J Microbiol ISSN: 2008-3289
Examined microbial acceptance level of Gouda cheese
| Coliforms | <10 |
| Negative | |
| Negative | |
| Mold and yeast | <102 |
| Coagulase-positive | Negative |
Samples of chitosan based nanocomposites
| 1 | 1 | 1 |
| 2 | 1 | 3 |
| 3 | 1 | 5 |
| 4 | 3 | 1 |
| 5 | 3 | 3 |
| 6 | 3 | 5 |
| 7 | 5 | 1 |
| 8 | 5 | 3 |
| 9 | 5 | 5 |
Samples of nanoclay based nanocomposites
| 1 | 1 | 1 |
| 2 | 1 | 3 |
| 3 | 1 | 5 |
| 4 | 3 | 1 |
| 5 | 3 | 3 |
| 6 | 3 | 5 |
| 7 | 5 | 1 |
| 8 | 5 | 3 |
| 9 | 5 | 5 |
Control samples
| 1 | 1 | 0 |
| 2 | 3 | 0 |
| 3 | 5 | 0 |
| 4 | 0 | 1 |
| 5 | 0 | 3 |
| 6 | 0 | 5 |
Antimicrobial activity of investigated nanoclay films
| 20 ± 0.23a | 15 ± 0.54c | 12 ± 0.35e | |
| 18 ± 0.11b | 12 ± 0.26e | NA | |
| 15 ± 0.34c | 13 ± 0.17d | 11 ± 0.25f | |
| 12 ± 0.82e | NA | NA | |
| 11 ± 0.15f | NA | NA | |
The results were reported as mean ± SD. The different letters in each column indicate significant differences.
NA: Not affected
Antimicrobial activity of investigated chitosan films
| 25 ± 0.22e | 39 ± 0.12b | 21 ± 0.41f | |
| 26 ± 0.15d | 39 ± 0.34b | 15 ± 0.61a | |
| 39 ± 0.23b | 49 ± 0.25a | 28 ± 0.11c | |
| 12 ± 0.31i | 15 ± 0.13h | 12 ± 0.15i | |
| 11 ± 0.28j | 16 ± 0.35g | 11 ± 0.18j | |
The results were reported as mean ± SD. The different letters in each column indicate significant differences.
Antimicrobial activity of investigated chitosan based nanocomposites
| 36 ± 0.67f | 33 ± 0.32h | 33 ± 0.53h | 39 ± 0.29d | 32 ± 0.46i | 31 ± 0.25j | 22 ± 0.28e | 20 ± 0.11q | 19 ± 0.27r | |
| 35 ± 0.23e | 30 ± 0.14e | 28 ± 0.45k | 40 ± 0.11c | 33 ± 0.24h | 33 ± 0.61h | 22 ± 0.21o | 21 ± 0.2p | 17 ± 0.39s | |
| 41 ± 0.21b | 35 ± 0.36g | 32 ± 0.32i | 52 ± 0.15a | 37 ± 0.36e | 36 ± 0.57f | 24 ± 0.39m | 25 ± 0.44l | 20 ± 0.43q | |
| 20 ± 0.37q | 15 ± 0.85e | 14 ± 0.16e | 25 ± 0.55l | 20 ± 0.19q | 19 ± 0.15r | 14 ± 0.52u | 13 ± 0.63v | 11 ± 0.52w | |
| 20 ± 0.52q | 17 ± 0.17s | 12 ± 0.22d | 23 ± 0.36n | 22 ± 0.1e | 19 ± 0.25r | 15 ± 0.15t | 15 ± 0.58s | 11 ± 0.31w | |
The results were reported as mean ± SD. The different letters in each column indicate significant differences.
C: Chitosan
N: Nanoclay
Antimicrobial activity of investigated nanoclay based nanocomposites
| 28 ± 0.67f | 32 ± 0.67e | 25 ± 0.67l | 29 ± 0.67h | 27 ± 0.67j | 24 ± 0.67m | 24 ± 0.67m | 22 ± 0.67n | 20 ± 0.67p | |
| 38 ± 0.67a | 38 ± 0.67a | 32 ± 0.67e | 36 ± 0.67c | 37 ± 0.67b | 29 ± 0.67h | 28 ± 0.67i | 24 ± 0.67m | 21 ± 0.67o | |
| 30 ± 0.67g | 35 ± 0.67d | 24 ± 0.6m | 28 ± 0.67i | 31 ± 0.67f | 25 ± 0.67l | 26 ± 0.67k | 21 ± 0.67o | 19 ± 0.67q | |
| 14 ± 0.67t | 16 ± 0.67r | 13 ± 0.67u | 11 ± 0.6w | 13 ± 0.67u | 12 ± 0.67v | 12 ± 0.67v | 11 ± 0.67w | 0 ± 0.67z | |
| 14 ± 0.67t | 15 ± 0.67s | 12 ± 0.67v | 12 ± 0.67v | 12 ± 0.67v | 11 ± 0.6w | 11 ± 0.67w | 11 ± 0.67w | 11 ± 0.6w | |
The results were reported as mean ± SD. The different letters in each column indicate significant differences.
C: Chitosan
N: Nanoclay